Log in to save to my catalogue

Chemo-Enzymatic Synthesis of Enantiopure β-Antagonist (S)-Betaxolol

Chemo-Enzymatic Synthesis of Enantiopure β-Antagonist (S)-Betaxolol

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2756675980

Chemo-Enzymatic Synthesis of Enantiopure β-Antagonist (S)-Betaxolol

About this item

Full title

Chemo-Enzymatic Synthesis of Enantiopure β-Antagonist (S)-Betaxolol

Publisher

Basel: MDPI AG

Journal title

Catalysts, 2022-12, Vol.12 (12), p.1645

Language

English

Formats

Publication information

Publisher

Basel: MDPI AG

More information

Scope and Contents

Contents

The β-blocker (S)-betaxolol has been synthesized in 99% enantiomeric excess (ee) from the commercially available precursor 4-(2-hydroxyethyl)phenol. The racemic chlorohydrin 1-chloro-3-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)propan-2-ol was esterified with vinyl acetate catalyzed by lipase B from Candida antarctica, which gave the R-chlorhydrin (R)...

Alternative Titles

Full title

Chemo-Enzymatic Synthesis of Enantiopure β-Antagonist (S)-Betaxolol

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2756675980

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2756675980

Other Identifiers

ISSN

2073-4344

E-ISSN

2073-4344

DOI

10.3390/catal12121645

How to access this item